Clinical Trial Update: The Effect of Combination of Dapagliflozin and Sildenafil in Treatment of Heart Failure Patients With Secondary Pulmonary Hypertension [NA]

View source ↗

Summary

A completed clinical trial evaluated the combination of dapagliflozin and sildenafil in patients with heart failure and secondary pulmonary hypertension.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure
• Pulmonary Hypertension

Drugs mentioned

• Dapagliflozin (dapagliflozin)
• SILDENAFIL (SILDENAFIL)

Snippet

Sponsor: Fayoum University | Conditions: Heart Failure NYHA Class II | NA | Status: COMPLETED